SGLT2 Inhibitors Vs. Finerenone for Slowing CKD Progression in Hypertensive Diabetic Patients With Obesity: A Comparative Effectiveness Study. JAPMI 2024, 2 (1), 21-236. https://doi.org/10.60087/Japmi.Vol.02.Issue.01.Id.016.